With Massachusetts-based Dragonfly BMS is taking a different tack and focusing on DF6002, a long-lasting fusion protein that looks like the “tail” (Fc) end of an IL-12 antibody. The companies ...

Antibodies are both blockbuster biopharmaceuticals and some of the most versatile reagents in the laboratory toolkit. But many antibody lines are not consistent or do not work as described ...

Received Clearance from the U.S. Food and Drug Administration (FDA) for Clinical Trials of Budoprutug in Primary Membranous Nephropathy (pMN), ...

Tonix Pharmaceuticals has reported positive topline outcomes from its Phase I single ascending dose study of its crystallisable fragment (Fc)-modified ... monoclonal antibody, TNX-1500, in healthy ...

In addition to enhancing the pharmacological properties of monoclonal antibodies, a detailed understanding of the function of their Fc receptors in health and disease has important implications ...